公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYnote-028 study | CHIUN HSU ; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J.; Saraf S.; Thanigaimani P.; Cheng J.D.; Hansen A.R. | Journal of Clinical Oncology | 315 | 280 | |
2020 | Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study | CHIA-CHI LIN ; Yang T.-S.; Yen C.-J.; Cheng R.; Liu J.; CHIUN HSU | Oncologist | 5 | 4 | |
2023 | Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma | BANG-BIN CHEN ; PO-CHIN LIANG ; TIFFANY TING-FANG SHIH ; TSUNG-HAO LIU ; YING-CHUN SHEN ; LI-CHUN LU ; ZHONG-ZHE LIN ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO | European radiology | 17 | 13 | |
2008 | Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer | YU-TING CHANG ; MING-CHU CHANG ; SHU-CHEN WEI ; YU-WEN TIEN ; CHIUN HSU ; PO-CHIN LIANG ; PO-NIEN TSAO ; I-SHIOW JAN ; Wong J.-M. | Pancreas | 60 | 51 | |
2005 | Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis | Ying-Chun Shen ; Chang C.-J.; CHIUN HSU ; Cheng C.-C.; Chiu C.-F.; ANN-LII CHENG | Cancer Epidemiology Biomarkers and Prevention | 127 | 116 | |
2017 | Simultaneous visualization of the subfemtomolar expression of microRNA and microRNA target gene using HILO microscopy | Lin Y.-Z.; DA-LIANG OU ; Chang H.-Y.; Lin W.-Y.; CHIUN HSU ; Chang P.-L. | Chemical Science | 14 | 13 | |
2009 | Sorafenib for the treatment of hepatocellular carcinoma across geographic regions | CHIUN HSU ; Ying-Chun Shen ; ANN-LII CHENG | Expert review of Clinical Pharmacology | 10 | 0 | |
2022 | Spectrum of cancer patients receiving renal biopsy | FAN-CHI CHANG ; WEI-WU CHEN ; TAO-MIN HUANG ; WEI-CHOU LIN ; Liu, Jia-Sin; WEN-CHIH CHIANG ; YUNG-MING CHEN ; CHIUN HSU ; KUN-HUEI YEH ; TZONG-SHINN CHU | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
2009 | Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy | CHIUN HSU ; SHU-CHEN WEI ; ANN-LII CHENG ; PEI-JER CHEN | Hepatology | 4 | 3 | |
2014 | Strategy for Preventing Hepatitis B Reactivation in Patients With Resolved Hepatitis B Virus Infection After Rituximab-Containing Chemotherapy Reply | CHIUN HSU ; PEI-JER CHEN ; ANN-LII CHENG | Hepatology | 0 | 0 | |
1996 | Surgical resection for recurrent hepatocellular carcinoma: Prognosis and analysis of risk factors | REY-HENG HU ; PO-HUANG LEE ; Yu S.-C.; HAO-CHIH TAI ; JIN-CHUAN SHEU ; Lai M.-Y.; CHIUN HSU ; DING-SHINN CHEN | Surgery | 91 | 82 | |
2005 | Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials | SUNG-HSIN KUO ; CHIH-HSIN YANG ; CHONG-JEN YU ; CHIUN HSU ; ANN-LII CHENG ; PAN-CHYR YANG | Lung Cancer | 7 | 7 | |
2006 | Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer | CHIH-HSIN YANG ; JIN-YUAN SHIH ; Chen K.-C.; CHONG-JEN YU ; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; CHIUN HSU ; Chang G.-C.; PAN-CHYR YANG | Cancer | 59 | 50 | |
2003 | Survival-weighted health profile for long-term survivors of acute myelogenous leukemia | CHIUN HSU ; Wang J.-D.; Hwang J.-S.; HWEI-FANG TIEN ; Chang S.-M.; ANN-LII CHENG ; YAO-CHANG CHEN ; JIH-LUH TANG | Quality of Life Research | 28 | 24 | |
2023 | Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinoma | ZHONG-ZHE LIN ; Hu, Mickey C-T; CHIUN HSU ; YAO-MING WU ; YEN-SHEN LU ; Ho, Ja-An Annie; Shiou-Hwei Yeh ; PEI-JER CHEN ; ANN-LII CHENG | Cancer letters | 1 | 1 | |
2024 | Translational research on drug development and biomarker discovery for hepatocellular carcinoma | Chew, Valerie; Chuang, Chien-Huai; CHIUN HSU | Journal of biomedical science | |||
2016 | Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges | LI-CHUN LU ; CHIH-HUNG HSU ; CHIUN HSU ; ANN-LII CHENG | Liver Cancer | 95 | 98 | |
2005 | Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate | CHING-HUNG LIN ; RUOH-FANG YEN ; YUNG-MING JENG ; Tzen C.-Y.; CHIUN HSU ; RUEY-LONG HONG | Head and Neck | 40 | 30 | |
2021 | The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma | Hung Y.-P.; YU-YUN SHAO ; CHIUN HSU ; CHIH-HUNG HSU ; Lee J.-M.; Yang M.-H.; Chao Y. | Journal of the Formosan Medical Association | 4 | 4 | |
2003 | Using standardised measures of health-related quality of life: Critical issues for users and developers | Kind, P.; CHIUN HSU ; Wang, J.-D.; KAI-PING GRACE YAO ; JIH-LUH TANG | Quality of Life Research | 3 | 1 |